Düsseldorf/Amsterdam, 20 September 2022 – As of September 2022 Holland Capital is a full member of The German Private Equity and Venture Capital Association (BVK). With this membership, Holland Capital confirms its commitment to the German private equity market.

BVK: face and voice of the private equity industry

BVK is the face and voice of the private equity industry in Germany, they campaign for improvements to the fiscal environment and for easier access to private equity so that even more companies in Germany can benefit from private equity. BVK takes a stand on policy issues and the media in an effort to underline how important private equity is for the German economy. They observe the market and analyse its trends, as private equity can be a growth engine for innovation, start-ups and SME’s. www.bvkap.de/en

Holland Capital is committed to the German market

Ewout Prins, managing partner Holland Capital, “Holland Capital has been active for over 40 years as a private equity investor within the Healthcare and Technology sectors in the Dutch market. We see interesting opportunities in the German market for our investment strategy. To support the expansion of our activities into the German market, we opened our Düsseldorf office last year. We look forward to working with German entrepreneurs, investors and advisers. As such, we are pleased to have become member of the BVK. We shall be happy to contribute to the German Private Equity industry”.

About Holland Capital

Over the past 40 years, Holland Capital has responsibly and successfully invested in over more than 150 SME-companies. With a clear investment strategy Holland Capital is active in the attractive growth markets of Healthcare and Technology. Holland Capital’s experienced and committed investment team aims to establish an open, sustainable, and professional relationship with the companies they invest in, with the common goal of achieving growth. Holland Capital is backed by a broad network of successful entrepreneurs in the relevant growth markets and has her offices in Amsterdam (NL) and Düsseldorf (D).

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Xilloc haalt groeifinanciering op bij investeerder Holland Capital Geleen/Amsterdam, 2 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is...

Yes We Can Healthcare Group bundelt krachten met Holland Capital

Yes We Can Healthcare Group bundelt krachten met Holland Capital Hilvarenbeek/Amsterdam, 1 juli 2021 – Holland Capital bundelt krachten met Yes We Can Healthcare Group (YWCHG),  een jeugdkliniek voor jongeren van 13-23 jaar met psychische problemen, verslavingen en...

Xilloc haalt groeifinanciering op bij investeerder Holland Capital

Geleen/Amsterdam, 1 juli 2021 – Xilloc, ontwikkelaar en producent van medische implantaten en hulpmiddelen, haalt financiering op bij Holland Capital voor internationale groeiambities. Xilloc is gespecialiseerd in het ontwerpen, produceren  en vermarkten vanmedische,...

Sirius Medical benoemt leden Raad van Commissarissen en nieuwe CEO

Sirius Medical benoemt leden Raad van Commissarissen en nieuwe CEO Eindhoven, 12 mei 2021 - Sirius Medical, een MedTech-startup die een innovatieve chirurgisch technologie heeft ontwikkeld om een tumoren te lokaliseren, heeft vandaag de benoemingen van de leden van de...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 311 94 11

 

Düsseldorf
Inselstraße 34
40479 Düsseldorf
+49 (0) 211 43 63 69 01